WRB Stock Analysis: W. R. Berkley | NYSE
Insurance - Property & Casualty | NYSE, USA | Market Cap: 27.076m USD | 12M Return: 9.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 143M
EPS Trend: 94.1%
Qual. Beats: 2
Rev. Trend: 99.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
W. R. Berkley Corporation (NYSE: WRB) is a U.S.-based insurance holding company that operates as a commercial line writer on a worldwide basis, distributing coverage through two segments: Insurance and Reinsurance & Monoline Excess. Founded in 1967 and headquartered in Greenwich, Connecticut, the company has been publicly traded since 1984 and is classified within the Financials sector as a Property & Casualty Insurance issuer.
The Insurance segment is the more diversified of the two, writing business across admitted lines, excess and surplus (E&S) lines, and specialty personal lines. Coverage offerings span accident and health, casualty, environmental, fine arts and jewelry, inland marine, commercial general liability, umbrella, professional liability, directors and officers, commercial property, surety, cyber risk, crime and fidelity, medical professional, workers compensation, management liability, energy and marine, and products tailored to the technology, life sciences, and travel industries. The segment also manages alternative risk programs and writes into the Lloyds marketplace.
The Reinsurance & Monoline Excess segment provides treaty and facultative reinsurance solutions to other insurers, including property and casualty reinsurance and monoline excess products. Facultative offerings include automatic, semi-automatic, and individual risk assumed reinsurance, along with turnkey products covering cyber, employment practices liability, liquor liability, and violent events.
As a specialty-focused commercial lines writer, Berkleys emphasis on E&S and reinsurance positions it in higher-margin, non-standard risk segments of the property and casualty market, where pricing and underwriting discipline tend to be more closely tied to individual risk characteristics than to standard market cycles.
- Specialty commercial lines premium growth sustains underwriting margins
- Catastrophe losses pressure combined ratio amid volatile weather
- Higher interest rates boost investment income on fixed maturity portfolio
| Net Income: 1.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.08 > 1.0 |
| NWC/Revenue: 69.71% < 20% (prev 71.26%; Δ -1.56% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.52b > Net Income 1.88b |
| Net Debt (299.8m) to EBITDA (2.36b): 0.13 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (399.1m) vs prev -1.01% < -2% |
| Gross Margin: 26.14% > 18% (prev 22.45%; Δ 3.69% > 0.5%) |
| Asset Turnover: 33.61% > 50% (prev 32.65%; Δ 0.96% > 0%) |
| Interest Coverage Ratio: 19.01 > 6 (EBIT TTM 2.41b / Interest Expense TTM 126.9m) |
| A: 0.23 (Total Current Assets 36.9b - Total Current Liabilities 26.5b) / Total Assets 45.7b |
| B: 0.29 (Retained Earnings 13.3b / Total Assets 45.7b) |
| C: 0.05 (EBIT TTM 2.41b / Avg Total Assets 44.2b) |
| D: 0.28 (Book Value of Equity 9.70b / Total Liabilities 34.4b) |
| Altman-Z'' = 3.10 = A |
As of July 22, 2026, the stock is trading at USD 72.16 with a total of 2,823,224 shares traded. Over the past week, the price has changed by +0.25%, over one month by +8.45%, over three months by +11.33% and over the past year by +9.38%.
Current recommended Stop Loss: 69.90 (which is 3.1% or 1.4 ATR below the current price).
W. R. Berkley has received a consensus analysts rating of 3.56. Therefore, it is recommended to hold WRB.
- StrongBuy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 68.3 | -5.4% |
P/E Trailing = 15.1837
P/E Forward = 15.5039
P/S = 1.8232
P/B = 2.7372
P/EG = 4.1892
Revenue TTM = 14.8b USD
EBIT TTM = 2.41b USD
EBITDA TTM = 2.36b USD
Long Term Debt = 2.84b USD (from longTermDebt, last fiscal year)
Short Term Debt = 61.5m USD (from shortTermDebt, last fiscal year)
Debt = 2.84b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 299.8m USD (calculated: Debt 2.84b - CCE 2.54b)
Enterprise Value = 27.4b USD (27.1b + Debt 2.84b - CCE 2.54b)
Interest Coverage Ratio = 19.01 (Ebit TTM 2.41b / Interest Expense TTM 126.9m)
EV/FCF = 8.12x (Enterprise Value 27.4b / FCF TTM 3.37b)
FCF Yield = 12.31% (FCF TTM 3.37b / Enterprise Value 27.4b)
FCF Margin = 22.70% (FCF TTM 3.37b / Revenue TTM 14.8b)
Net Margin = 12.64% (Net Income TTM 1.88b / Revenue TTM 14.8b)
Gross Margin = 26.14% ((Revenue TTM 14.8b - Cost of Revenue TTM 11.0b) / Revenue TTM)
Gross Margin QoQ = 47.51% (prev 20.58%)
Tobins Q-Ratio = 0.60 (Enterprise Value 27.4b / Total Assets 45.7b)
Interest Expense / Debt = 4.47% (Interest Expense 126.9m / Debt 2.84b)
Taxrate = 20.15% (475.0m / 2.36b)
NOPAT = 1.93b (EBIT 2.41b * (1 - 20.15%))
Current Ratio = 1.39 (Total Current Assets 36.9b / Total Current Liabilities 26.5b)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last fiscal year 9.70b)
Debt / EBITDA = 0.13 (Net Debt 299.8m / EBITDA 2.36b)
Debt / FCF = 0.09 (Net Debt 299.8m / FCF TTM 3.37b)
Total Stockholder Equity = 9.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 1.88b / Total Assets 45.7b)
RoE = 19.48% (Net Income TTM 1.88b / Total Stockholder Equity 9.63b)
RoCE = 19.34% (EBIT 2.41b / Capital Employed (Equity 9.63b + L.T.Debt 2.84b))
RoIC = 10.44% (NOPAT 1.93b / Invested Capital 18.5b)
WACC = 5.56% (E(27.1b)/V(29.9b) * Re(5.77%) + D(2.84b)/V(29.9b) * Rd(4.47%) * (1-Tc(0.20)))
Discount Rate = 5.77% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.09 | Cagr: -1.29%
[DCF] Terminal Value 74.50% ; FCFF base≈3.47b ; Y1≈3.29b ; Y5≈3.11b
[DCF] Fair Price = 130.7 (EV 48.9b - Net Debt 299.8m = Equity 48.6b / Shares 372.3m; r=8.35% [WACC [floored]]; 5y FCF grow -6.60% → 2.50% )
EPS Correlation: 94.12 | EPS CAGR: 13.99% | SUE: 2.18 | # QB: 2
Revenue Correlation: 99.28 | Revenue CAGR: 10.02% | SUE: 0.53 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.09 | Chg30d=+0.02% | Revisions=-17% | Analysts=14
EPS current Year (2026-12-31): EPS=4.66 | Chg30d=-0.36% | Revisions=-29% | GrowthEPS=+7.5% | GrowthRev=+3.2%
EPS next Year (2027-12-31): EPS=4.79 | Chg30d=-0.53% | Revisions=-57% | GrowthEPS=+2.9% | GrowthRev=+4.2%
[Analyst] Revisions Ratio: -50% (up=2, down=9)